ISRCTN38929731已完成不适用
Comparison of radical radiotherapy with or without chemotherapy for poor prognosis carcinoma of cervix
Cancer Research UK (CRUK) (UK)0 个研究点目标入组 0 人开始时间: 2001年7月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Histologically diagnosed squamous cell carcinoma of the cervix uteri
- •2. International Federation of Gynecology and Obstetrics (FIGO) stage III, IVa or bulky stage II
- •3. No evidence of extra pelvic spread
- •4. Aged <70 years
- •5. World Health Organisation (WHO) performance 0-2
- •6. Suitable for radical radiotherapy
- •7. Suitable for chemotherapy
- •8. Adequate haematological and renal function
- •9. No history of previous malignancy, excluding successfully treated squamous and basal cell carcinoma of skin or carcinoma in situ of the cervix
- •10. No previous chemotherapy or radiotherapy
- •11. No contraindications to treatment
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
不适用
A trial to compare radiotherapy alone with radiotherapy followed by chemotherapy in the treatment of non-Hodgkin's lymphomaymphoma (non-Hodgkin's)Lymphoma (non-Hodgkin's)CancerISRCTN18173987Cancer Research UK (CRUK) (UK)
进行中（未招募）
1 期
ABiochemically-relapsing prostate adenocarcinoma following radical prostatectomy.MedDRA version: 14.1 Level: LLT Classification code 10001186 Term: Adenocarcinoma of prostate System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-004831-30-FRICANCER43
招募中
2 期
Radiotherapy to all involved sites in advanced prostate cancerCTRI/2022/10/046239Intramural Tata memorial Centre
招募中
2 期
Radiotherapy of soft tissue sarcomaIRCT20180919041070N3Iran University of Medical Sciences80
已完成
不适用
A randomised trial of radiotherapy alone versus three cycles of cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP) chemotherapy plus radiotherapy versus six cycles of CHOP chemotherapy plus radiotherapy for early stage aggressive non-Hodgkin's lymphomaon-Hodgkin's lymphomaNon-Hodgkin's lymphomaCancerISRCTN55593137Cancer Research UK (CRUK) (UK)